HBSN Reading Tools
How to cite item
Atezolizumab plus bevacizumab and tremelimumab plus durvalumab: how should we choose these two immunotherapy regimens for advanced hepatocellular carcinoma?
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{HBSN}{104617}, author = {Hatanaka, T., Naganuma, A., Yata, Y., Kakizaki, S.}, title = {Atezolizumab plus bevacizumab and tremelimumab plus durvalumab: how should we choose these two immunotherapy regimens for advanced hepatocellular carcinoma?}, journal = {Hepatobiliary Surgery and Nutrition}, volume = {11}, number = {6}, year = {2022}, url = {https://hbsn.amegroups.org/article/view/104617} }